Status:
COMPLETED
Primary Care Internet Based Depression Prevention for Adolescents (CATCH-IT) Also Known as Promoting AdolescenT Health
Lead Sponsor:
Benjamin Van Voorhees, MD, MPH
Collaborating Sponsors:
Wellesley College
Northwestern University
Conditions:
Major Depression
Depressive Episodes
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
The purpose of this randomized multiple-site clinical study is to determine whether a revised CATCH-IT (Internet-based depression prevention program) is more effective than a general health education ...
Detailed Description
Additional aims and hypothesis are provided below: -Aim 1: To determine whether the CATCH-IT depression prevention intervention prevents or delays major depressive episodes, as well as non-affective ...
Eligibility Criteria
Inclusion
- Adolescents:
- (A) Youth ages 13 through 18 who are English speaking. (B) Youth must be experiencing elevated level of depressive symptoms on the Center for Epidemiologic Studies Depression (CES-D) scale (score \>/= 16). (C) Youth will be included if they have a past history of depression, anxiety, externalizing symptoms, or substance abuse. Youth presenting in partial remission from a major depressive episode at Baseline will be rescreened after 2 months utilizing the phone screen to ensure episode is fully remitted prior to randomization or access to study intervention. Those who do not fully remit after two months will be excluded.
- Parents:
- \*Parent of eligible adolescents
- Physicians (PCP) or NP:
- \*Physician in any of the study sites
- Healthcare Professionals:
- \*Primary care practice for a minimum of 6 months
Exclusion
- Adolescents:
- Current DSM-IV diagnosis of Major Depressive Disorder
- Current therapy for depression, or be taking antidepressants (e.g., SSRIs, TCAs, MAOIs, bupropion, nefazodone, mirtazapine, venlafaxine);
- Current CES-D score \>35;
- DSM-IV diagnosis of schizophrenia (current or past) or bipolar affective disorder;
- Current serious medical illness that causes significant disability or dysfunction;
- Significant reading impairment (a minimum sixth-grade reading level based on parental report), mental retardation, or developmental disabilities;
- Serious imminent suicidal risk (as determined by endorsement of current suicide on CES-D or in KSADS interview) or other conditions that may require immediate psychiatric hospitalization
- Psychotic features or disorders, or currently be receiving psychotropic medication
- Extreme, current drug/alcohol abuse (greater than or equal to 2 on the CRAFFT).
- Parents:
- Ineligible child
- Non-English speaking
- Physicians:
- \*None
- Healthcare Professionals:
- \*None
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
1142 Patients enrolled
Trial Details
Trial ID
NCT01893749
Start Date
February 1 2012
End Date
July 1 2016
Last Update
August 22 2019
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
ACCESS Healthcare Systems
Chicago, Illinois, United States, 60606
2
University of Illinois
Chicago, Illinois, United States, 60612
3
Northshore Healthcare Systems
Evanston, Illinois, United States, 60201
4
Advocate Health Care
Oak Lawn, Illinois, United States, 60453